Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
10/2005
10/06/2005US20050222201 such as 3-(2-chloro-4-quinolinyl)-2,5-dimethyl-1H-indole-1-acetic acid, used for treating respiratory system disorders and as inhibitors of G protein-coupled receptor chemoattractant homologous receptor expressed on lymphocyte cells (CRTH2)
10/06/2005US20050222194 3-[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-quinolin-2(1H)-ones or 5--[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-pyrrolo[3,2,1-IJ]quinolin-4(4H)-ones; type E antagonists; analgesics, antipyretics, antiinflammatory agents; side effect reduction
10/06/2005US20050222193 Novel combination for the treatment of airway disorders
10/06/2005US20050222189 Oxa-and thiadiazoles and their use as metalloproteinase inhibitors
10/06/2005US20050222186 Substituted diaminopyrimidines
10/06/2005US20050222182 Stabilized pharmaceutical compositions of halofuginone and other quinazolinone derivatives
10/06/2005US20050222179 Adenosine receptor antagonists and methods of making and using the same
10/06/2005US20050222160 1-[3-(3-cyclopentyloxy-4-methoxyphenyl)-3,4,5,6-tetrahydropyridazin-1-yl]-1-[4-methyl-2-(1-oxypyridin-2-yl)thiazol-5-yl]methanone, used for inhibiting proliferation of lymphocytes in a host, and for the treatment of osteoporosis, tumors, cachexia, atherosclerosis, arthritis, multiple sclerosis, diabetes
10/06/2005US20050222152 Enzyme inhibitors for disease treatment with Cathepsin s
10/06/2005US20050222147 Process for the preparation of morpholine derivatives and intermediates therefore
10/06/2005US20050222138 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient
10/06/2005US20050222118 For therapy of inflammatory or allergic condition
10/06/2005US20050222087 Hedgehog antagonists that inhibit the hedgehog pathway in a smoothened gain-of-function cell with an IC50 within a factor of 20, 10, or even a factor of 5, of the IC50 with which they inhibit the hedgehog pathway in a patched-null cell
10/06/2005US20050222062 Decoy for treating and/or preventing th2 cytokine-associated allergic disease, gata3 mutant protein and medicinal compositions containing the same
10/06/2005US20050221483 Propagating pluripotent stem cells from monocytes; tissue engineering; cell therapy; treating cardiovascular, arteriosclerotic, metabolic and liver disorders; cell expressing albumin protein; cirrhosis of the liver
10/06/2005US20050221368 Methods for identifying RNA binding compounds
10/06/2005US20050221347 Inhibitors of binding between proteins and macromolecular ligands
10/06/2005US20050221330 Glial cell line-derived neurotrophic factor (GDNF); nervous system disorders, autonomic nervous system, shingles, asthma, irritable bowel, inflammatory bowel, constipation, headache, arthritis, spinal cord injury, chronic back pain, hypertension, mucositis, diabetes, fibromyalgia, and wound healing
10/06/2005US20050221287 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs53 upregulation
10/06/2005US20050220859 Methods for treating illnesses of the tracheo-bronchial tract, especially chronic obstructive pulmonary disease (COPD)
10/06/2005US20050220852 Adhesive patch containing tulobuterol
10/06/2005US20050220851 Matrix type patch containing bronchodilators
10/06/2005US20050220805 Polynucleotide sequence for Chalmydia pneumonia; therapy, prevention of Chlamydia infections ; vaccines
10/06/2005US20050220784 Quinazoline derivatives as medicaments
10/06/2005US20050220767 Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules
10/06/2005US20050220716 Drug delivery assembly
10/06/2005CA2561696A1 Novel modified galectin 9 proteins and use thereof
10/06/2005CA2561495A1 Truncated dance, dance complex and method of using these
10/06/2005CA2560368A1 Compounds for the treatment of diseases
10/06/2005CA2559465A1 Herbal therapy for the treatment of asthma
10/06/2005CA2558067A1 Novel benzoxazinone derivatives used as long-acting betamimetics for treating respiratory illnesses
10/06/2005CA2557745A1 Bicyclic substituted indole-derivative steroid hormone nuclear receptor modulators
10/06/2005CA2534445A1 Agent for promoting hgf production comprising heparin-like oligosaccharides
10/05/2005EP1582586A1 Apoptosis-associated protein and use thereof
10/05/2005EP1582521A1 Fused furan compound
10/05/2005EP1582210A2 Compositions and methods for treating or preventing surgical adhesions
10/05/2005EP1581616A2 Novel proteins and nucleic acids encoding same
10/05/2005EP1581533A2 Novel benzonaphthyridines
10/05/2005EP1581517A1 Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
10/05/2005EP1581511A1 Ccr8 inhibitors
10/05/2005EP1581507A1 Benzamide inhibitors of the p2x7 receptor
10/05/2005EP1581237A1 Development of an anti-cough, anti-tussive and throat soothing herbal formulation
10/05/2005EP1581236A2 Sustained release of antiinfectives
10/05/2005EP1581224A1 Tiotropium-containing medicament combinations used for inhaling
10/05/2005EP1581223A2 Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists
10/05/2005EP1581198A1 Powdered medicament for inhalation comprising a tiotropium salt and salmeterol xinafoate
10/05/2005EP1325008B1 Piperazine derivatives
10/05/2005EP1272168B1 Small organic molecule regulators of cell proliferation
10/05/2005EP1263430B1 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases
10/05/2005EP1233950B1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/P39 kINASE INHIBITORS
10/05/2005EP1202733B1 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents
10/05/2005EP1183233B1 Bradykinin receptor antagonists
10/05/2005EP1077936B1 Novel analogs of 16-hydroxyeicosatetraenoic acid
10/05/2005CN1678620A Macrolide compounds endowed with antiinflammatory activity
10/05/2005CN1678610A New quinuclidine amide derivatives
10/05/2005CN1678606A Novel crystals
10/05/2005CN1678594A Morpholin-acetamide derivatives for the treatment of inflammatory diseases
10/05/2005CN1678579A Indole-3-sulphur derivatives
10/05/2005CN1678573A Diarylurea derivatives and their use as chloride channel blockers
10/05/2005CN1678572A Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
10/05/2005CN1678338A Method and composition for regulating the activity of regulatory T cells
10/05/2005CN1678337A Amelioration of effects of cigarette smoke
10/05/2005CN1678334A New plant based agents as bioavailability/bioefficacy enhancers for drugs and nutraceuticals
10/05/2005CN1678332A Novel therapeutic use of polypodium extracts
10/05/2005CN1678330A Antiallergic agent, utilization thereof for reducing allergy and method of reducing allergy
10/05/2005CN1678325A Sapogenin derivatives, their synthesis and use and method based upon the use
10/05/2005CN1678320A N-biarylmethyl aminocycloalkanecarboxamide derivatives
10/05/2005CN1678318A Medicament compositions based on tiotropium salts and on salmeterol salts
10/05/2005CN1678317A 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(NK-1) antagonists for the treatment of emesis, depression, anxiety and cough
10/05/2005CN1678307A Treatment of non-allergic rhinitis by means of selective phosphodiesterase-4 inhibitors
10/05/2005CN1678188A Nucleic acid compositions for stimulating immune responses
10/05/2005CN1676520A Kuh-seng flavone extract and preparation and use thereof
10/05/2005CN1676162A Thymic penta peptide injection liquid
10/05/2005CN1676161A Chinese medicine formulation for treating upper respiratory system disease, skin infection and haemorr hoids and its preparing method
10/05/2005CN1676133A Doxufylline for injection and its preparing method
10/05/2005CN1221570C Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant
10/05/2005CN1221551C Aminotriazolopyridine derivatives as adenosine receptor ligands
10/05/2005CN1221549C Crystalline monohydrate, method for producing the same and the use thereof in the production of medicament
10/05/2005CN1221544C Pyrazole cyclic AMP-specific PDE inhibitors
10/05/2005CN1221536C New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl- pyrimidines, their preparation and application as medication
10/05/2005CN1221535C Spiroimidazolidine derivatives, their prepn. their use and pharmaceutical preparation comprising them
10/05/2005CN1221534C Substited 8-arylquinoline phosphodiesterase-4 inhibitors
10/05/2005CN1221277C Medication for preventing and treating pneumonia, bronchitis, pharyngitis and upper respiratory tract infection as well as its preparing method
10/05/2005CN1221275C Throat lozenge
10/05/2005CN1221253C Application of tea polyphenol in medicine to treat diseases in respiratory system
10/04/2005US6951950 such as (3S)-3-(2-amino-2-oxo-1,1-diphenylethyl)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]-1-methylpyrrolidinium iodide for treatment of asthma, chronic obstructive pulmonary disorder, allergic rhinitis, and infectious rhinitis
10/04/2005US6951940 Analgesics, antiinflammatory agents, antiallergens, autoimmune disease, cardiovascular disorders
10/04/2005US6951918 Treatment of diseases characterized by excessive deposits of fibrillar interstitial collagens that are resistant to proteolyic degradation thus leading to symptoms of fibrosis
10/04/2005US6951889 7-acetamidinyl derivatives
10/04/2005US6951876 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents
10/04/2005US6951874 Compounds
10/04/2005US6951871 Indole derivatives useful as histamine H3 antagonists
10/04/2005US6951865 Fused heterotricyclic compounds, process for preparing the compounds and drugs containing the same
10/04/2005US6951863 Pyridoarylphenly oxazolidinone antibacterials, and related compositions and methods
10/04/2005US6951861 Chemical compounds
10/04/2005US6951857 Interleukins; cytokines; for treating eosinophil-dependent inflammatory disease/bronchial asthma
10/04/2005US6951856 Substituted pyrimidine-sulfonamide derivatives are used as endothelin receptor antagonists
10/04/2005US6951851 Substituted pyrazoles
10/04/2005US6951845 Method for treating allergic lung disease
10/04/2005US6951732 Virulence genes, proteins, and their use
1 ... 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 ... 878